Title : Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients.

Pub. Date : 2011 Oct

PMID : 21902501






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients. Methadone cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 The isozyme CYP3A4 of the CYP system is one of the metabolic enzymes, as well as CYP2B6, responsible for the metabolism of methadone. Methadone cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 The aim of the present study is to evaluate the potential use of genetic polymorphisms in CYP3A4 as biomarkers for the prediction of methadone treatment responses. Methadone cytochrome P450 family 3 subfamily A member 4 Homo sapiens
4 CONCLUSION: These results suggested that genetic variants in the CYP3A4 gene may be useful indicators for the severity of side effects and withdrawal symptoms for methadone treatment. Methadone cytochrome P450 family 3 subfamily A member 4 Homo sapiens